DISCLAIMER: This site is for informational purposes only. While we make every effort to keep it up to date, there is no guarantee that information is complete, accurate, comprehensive, or the same for all KP regions. The information on this site should not be interpreted or used as a substitute for professional medical care. Please consult your care provider for any personal health questions or before participating in clinical trials.

Active, currently enrolling

Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment

NCT No.: NCT05893498

Study Type: OBSERVATIONAL

Phase:

Region: California - Northern

Acronym: ALLRISE

Official Title

Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment

Purpose

ALL-RISE is a prospective, randomized, multi-center, controlled post-market study. The ALL-RISE study is designed to test whether FFRangio-guided treatment is non-inferior to conventional pressure wire-guided treatment in patients with coronary artery disease being evaluated for percutaneous coronary intervention (PCI) with respect to major adverse cardiac events (MACE) at one year.

Detailed Description

Sex

Male & Female

Age Limit

Eligibility Criteria

Inclusion Criteria

1. Adult patient ( ≥18 years old) presenting with CCS or NSTEACS with one or more study lesion(s) deemed appropriate (diameter stenosis 50-90%) for both pressure-wire and FFRangio physiologic assessment.

Exclusion Criteria

1. Subject with ST-elevation (MI (STEMI) within 72 hours at time of study enrollment

2. Prior coronary artery bypass graft (CABG) with patent grafts to the study vessel(s)

3. Patients undergoing coronary physiologic assessment where one possible outcome is referral for CABG

4. The study vessel supplies a significant nonviable territory (e.g., prior transmural MI)

5. Severe left sided valvular heart disease

6. Most recent documented LVEF ≤30%

7. Women who are pregnant or breastfeeding (women of childbearing potential are required to have negative pregnancy test within 1 week of index procedure)

8. Patients with life expectancy <1 year life as estimated by treating physician.

9. Subjects enrolled in other ongoing non-registry clinical studies that would impact conduct or outcomes of this study (registries and long-term follow-up of other studies are allowed)

10. Subjects who have undergone angiographic or wire-based coronary physiological assessment for 1 or more potential study lesions within 30 days of enrollment.

Keywords and/or Specific Medical Conditions

  • Cardiology
  • Surgery (General)
  • Surgery (Thoracic)

Sponsors

  • CathWorks Ltd.

KP Clinical Facility

Clinical Area

  • Cardiology
  • Surgery (General)
  • Surgery (Thoracic)

Principal Investigator

Gopi Manthripragada  

Contact Information

 - CTP Collaborate Team
- CTPCollaborate@kp.org
- All Kaiser Permanente Northern California Medical Centers

Find a study